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Purpose of the study
To assess if with current cART regimens the number of
daily pills is still a determinant of adherence and quality
of life (QOL).
Methods
Cross-sectional study of patients (pts) on cART followed
at our centre. An adherence and QOL questionnaire
was offered between March and May 2010 to all pts at
San Raffaele Scientific Institute, Infectious Diseases, Milano, Italy
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scale. Results are described as median (IQR) or fre-
quency (%). Linear correlation was evaluated by the
Spearman correlation coefficient. Generalized linear
model (GLM) was applied considering adherence or
QOL as alternative outcome variables.
Results
2114 pts [aged 46.3 (41.9-51.1) years, 448 (21.3%)
females, infected since 13.7 (8.0-19.2) years, treated with
antiretrovirals since 11.5 (5.4-14.1) years, 260 (12.4%) of
whom with a previous diagnosis of AIDS] were included
in the analysis.
At the time of survey, 1793 (87%) had <50 HIV RNA
copies/mL and CD4+ were 570 (403-746)/µL. Adher-
ence and QOL were 100 (100-100)% and 83 (61-100)%,
respectively; the number of daily pills in the ongoing
regimen was 3 (3-5); 914 (43.2%) pts were receiving a
BID and 1200 (56.8%) a QD regimen. At univariate ana-
lysis (figure 1), adherence was correlated to QOL but
not to the number of daily pills, whereas QOL was
weakly and inversely related to the number of daily pills;
both adherence and QOL were not different between
pts receiving a BID or QD regimen.
At GLM, after adjustment for age, gender, HIV risk
factor, current CD4+, number of pills or dosing interval,
adherence was associated with current HIV RNA
[adjusted mean±SE: 94.3±0.48% for pts with <50 copies/
mL vs 88.6±1.10% for those with ≥50 copies/mL,
p<0.0001], gender [90.4±0.94% for females vs 92.5
±0.60% for males, p=0.023] and current CD4+ (b=0.003
p<0.001).
When adjusting for the same variables, QOL was
higher in pts with undetectable viremia (78.7±0.7% vs
74.0±1.58%; p=0.004), in males (78.3±0.89% vs 74.5
±1.39%; p=0.009), in MSMs vs heterosexuals vs others
[78.5±1.37% (p<0.0001) vs 77.2±1.33% (p=0.008) vs 73.3
±1.07% (reference group)], and also associated with age
(b=-0.25, p<0.0001), current CD4+ (b=0.011, p<0.0001),
and the number of pills (b=-0.77, p=0.019), but not with
dosing interval.
Conclusions
In this highly adherent population, adherence was not
associated with the number of daily pills or dosing inter-
val. QOL was associated with the pill burden, but the
pill burden explained <1% of QOL. Both adherence and
QOL were strongly associated with virological response.
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